» Articles » PMID: 31145099

Sex Differences in IL-17 Contribute to Chronicity in Male Versus Female Urinary Tract Infection

Overview
Journal JCI Insight
Date 2019 May 31
PMID 31145099
Citations 45
Authors
Affiliations
Soon will be listed here.
Abstract

Sex-based differences influence incidence and outcome of infectious disease. Women have a significantly greater incidence of urinary tract infection (UTI) than men, yet, conversely, male UTI is more persistent with greater associated morbidity. Mechanisms underlying these sex-based differences are unknown, in part due to a lack of experimental models. We optimized a model to transurethrally infect male mice and directly compared UTI in both sexes. Although both sexes were initially equally colonized by uropathogenic E. coli, only male and testosterone-treated female mice remained chronically infected for up to 4 weeks. Female mice had more robust innate responses, including higher IL-17 expression, and increased γδ T cells and group 3 innate lymphoid cells in the bladder following infection. Accordingly, neutralizing IL-17 abolished resolution in female mice, identifying a cytokine pathway necessary for bacterial clearance. Our findings support the concept that sex-based responses to UTI contribute to impaired innate immunity in males and provide a rationale for non-antibiotic-based immune targeting to improve the response to UTI.

Citing Articles

Single-cell RNA sequencing and spatial transcriptome analysis in bladder cancer: Current status and future perspectives.

Yoshihara K, Ito K, Kimura T, Yamamoto Y, Urabe F Bladder Cancer. 2025; 11(1):23523735251322017.

PMID: 40034247 PMC: 11864234. DOI: 10.1177/23523735251322017.


Influence of meteorological and environmental factors on pediatric urinary tract infections: insights from a 6-year retrospective study in Central China.

Li C, Tang F, Xi L, Wang X Front Public Health. 2025; 13:1512403.

PMID: 40017552 PMC: 11864906. DOI: 10.3389/fpubh.2025.1512403.


Overcoming challenges in the management of recurrent urinary tract infections.

Cornelius S, Basu U, Zimmern P, De Nisco N Expert Rev Anti Infect Ther. 2024; 22(12):1157-1169.

PMID: 39387179 PMC: 11634670. DOI: 10.1080/14787210.2024.2412628.


A Dynamic Interplay of Innate Immune Responses During Urinary Tract Infection.

Naskar M, Choi H Immune Netw. 2024; 24(4):e31.

PMID: 39246616 PMC: 11377947. DOI: 10.4110/in.2024.24.e31.


Role of the type 3 cytokines IL-17 and IL-22 in modulating metabolic dysfunction-associated steatotic liver disease.

Abdelnabi M, Hassan G, Shoukry N Front Immunol. 2024; 15:1437046.

PMID: 39156888 PMC: 11327067. DOI: 10.3389/fimmu.2024.1437046.


References
1.
Luthje P, Brauner H, Ramos N, Ovregaard A, Glaser R, Linden Hirschberg A . Estrogen supports urothelial defense mechanisms. Sci Transl Med. 2013; 5(190):190ra80. DOI: 10.1126/scitranslmed.3005574. View

2.
Balemans L, Vegt P, Steerenberg P, de Boer E, Van Swaaij A, de Vries R . Effects of sequential intravesical administration of mitomycin C and bacillus Calmette-Guérin on the immune response in the guinea pig bladder. Urol Res. 1994; 22(4):239-45. DOI: 10.1007/BF00541900. View

3.
Carey A, Sullivan M, Duell B, Crossman D, Chattopadhyay D, Brooks A . Uropathogenic Escherichia coli Engages CD14-Dependent Signaling to Enable Bladder-Macrophage-Dependent Control of Acute Urinary Tract Infection. J Infect Dis. 2015; 213(4):659-68. DOI: 10.1093/infdis/jiv424. View

4.
Walker J, McKenzie A . Development and function of group 2 innate lymphoid cells. Curr Opin Immunol. 2013; 25(2):148-55. PMC: 3776222. DOI: 10.1016/j.coi.2013.02.010. View

5.
Vom Steeg L, Klein S . SeXX Matters in Infectious Disease Pathogenesis. PLoS Pathog. 2016; 12(2):e1005374. PMC: 4759457. DOI: 10.1371/journal.ppat.1005374. View